# FDA recall D-1412-2012

> **GlaxoSmithKline Inc** · Class II · drug recall initiated 2012-06-04.

## Product

Trizivir (abacavir sulfate 300mg, lamivudine 150 mg and zidovudine 300 mg), 60 Tablets, Rx only, Manufactured for: ViiV Healthcare, Research Triangle Park, NC 27709 by: GlaxoSmithKline, Research Triangle Park, NC 27709, NDC 49702-217-18

## Reason for recall

Adulterated Presence of Foreign Tablets: Trizivir 300/150/300 mg tables, Lot 0ZP5128 may incorrectly contain Lexiva 700 mg tablets.

## Distribution

Nationwide

## Key facts

- **Recall number:** D-1412-2012
- **Recalling firm:** GlaxoSmithKline Inc
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2012-06-04
- **Report date:** 2012-07-18
- **Termination date:** 2014-09-04

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Zebulon, NC, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1412-2012

## Citation

> AI Analytics. FDA recall D-1412-2012. Retrieved 2026-05-25 from https://api.ai-analytics.org/recall/D-1412-2012. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*